In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.

We tested the activity of the new fluoroquinolone sparfloxacin (CI-978; AT 4140) against 30 strains of Mycobacterium avium complex (MAC) isolated from patients with acquired immune deficiency syndrome. MICs of sparfloxacin (range, less than or equal to 0.06 to 4 micrograms/ml) were lower than MICs o...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Yajko, D M, Sanders, C A, Nassos, P S, Hadley, W K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172081/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2088204/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.12.2442
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!